Screening young adult cancer survivors for depression and anxiety with the Primary Care Evaluation of Mental Disorders (PRIME-MD): Comparisons with a structured clinical diagnostic interview.
PRIME-MD
SCID
anxiety
cancer
depression
psycho-oncology
validation
young adult cancer survivors
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
revised:
01
05
2023
received:
19
01
2023
accepted:
09
05
2023
medline:
10
7
2023
pubmed:
24
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
Survivorship guidelines recommend screening for depression and anxiety in young adult cancer survivors (YACS), but research validating measures in this population is limited. The current study aimed to examine use of the Primary Care Evaluation of Mental Disorders (PRIME-MD) to screen for depression and anxiety in YACS. 249 YACS (aged 18-40, 50% male) completed PRIME-MD via Telephone Automated Computer Assisted Structured Interview and the Structured Clinical Interview for the DSM-IV (SCID) via in-person interview. SCID responses were scored to identify depressive and anxiety symptoms and diagnoses. PRIME-MD was scored to identify YACS reaching the symptom threshold (≥1 depressive or anxiety symptom) and diagnostic threshold for depressive or anxiety disorder. ROC analyses evaluated concordance of the PRIME-MD with the SCID. The PRIME-MD depressive symptom threshold had excellent discrimination compared to SCID depressive diagnosis (AUC = 0.83) with high sensitivity (86%) and specificity (81%). Similarly, the PRIME-MD depressive diagnosis threshold had excellent discrimination compared to SCID depressive diagnosis (AUC = 0.86) as well as high sensitivity (86%) and specificity (86%). No PRIME-MD threshold met sensitivity (≥0.85) and specificity (≥0.75) criteria for identifying SCID depressive symptoms, anxiety disorders, or anxiety symptoms. PRIME-MD has potential utility as a screening measure of depressive disorders in YACS. The PRIME-MD depressive symptom threshold may be particularly useful in survivorship clinics as it requires only two items be administered. However, PRIME-MD does not meet study criteria for a standalone screen for anxiety disorders, anxiety symptoms, or depressive symptoms in YACS.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1122-1129Subventions
Organisme : NCI NIH HHS
ID : 5R21CA161315
Pays : United States
Organisme : NCI NIH HHS
ID : 5R21CA161315
Pays : United States
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics. CA a Cancer J Clin. 2022;72(5):409-436. https://doi.org/10.3322/caac.21731
Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2396-2404. https://doi.org/10.1200/jco.2008.21.1433
Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721-732. https://doi.org/10.1016/s1470-2045(13)70244-4
Sanft T, Denlinger CS, Armenian S, et al. NCCN guidelines insights: survivorship, version 2.2019. J Natl Compr Canc Netw. 2019;17(7):784-794. https://doi.org/10.6004/jnccn.2019.0034
Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Children's Oncology Group, 2018.
Michel G, Vetsch J. Screening for psychological late effects in childhood, adolescent and young adult cancer survivors: a systematic review. Curr Opin Oncol. 2015;27(4):297-305. https://doi.org/10.1097/cco.0000000000000196
Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101(21):1464-1488. https://doi.org/10.1093/jnci/djp336
Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749-1756. https://doi.org/10.1001/jama.272.22.1749
Kobak KA, Taylor LH, Dottl SL, et al. Computerized screening for psychiatric disorders in an outpatient community mental health clinic. Psychiatr Serv. 1997;48:1048-1057.
Kobak KA, Taylor LH, Dottl SL, et al. A computer-administered telephone interview to identify mental disorders. JAMA. 1997;278(11):905-910. https://doi.org/10.1001/jama.1997.03550110043034
Rollman BL, Belnap BH, Mazumdar S, et al. Symptomatic severity of PRIME-MD diagnosed episodes of panic and generalized anxiety disorder in primary care. J Gen Intern Med. 2005;20(7):623-628. https://doi.org/10.1007/s11606-005-0108-2
Recklitis CJ, Blackmon JE, Chang G. Validity of the brief symptom inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: comparison with a structured clinical diagnostic interview. Psychol Assess. 2017;29(10):1189-1200. https://doi.org/10.1037/pas0000427
Recklitis CJ, Blackmon JE, Chang G. Screening young adult cancer survivors with the PROMIS Depression Short Form (PROMIS-D-SF): comparison with a structured clinical diagnostic interview. Cancer. 2020;126(7):1568-1575. https://doi.org/10.1002/cncr.32689
Recklitis CJ, Blackmon JE, Chevalier LL, Chang G. Validating the Patient-Reported Outcomes Measurement Information System Short Form v1. 0-Anxiety 8a in a sample of young adult cancer survivors: comparison with a structured clinical diagnostic interview. Cancer. 2021;127(19):3691-3697. https://doi.org/10.1002/cncr.33683
Chevalier LL, Blackmon JE, Bober SL, Roman A, Chang G, Recklitis CJ. Evaluating sensitive symptoms in young adult cancer survivors: acceptability of suicidal ideation and sexual health items across administration modes. J Cancer Surviv. 2022:1-7. https://doi.org/10.1007/s11764-022-01237-5
Keim-Malpass J, Alcalá HE. Association of age at cancer diagnosis and clinical trial participation. JAMA Netw Open. 2021;4(2):e2037573. https://doi.org/10.1001/jamanetworkopen.2020.37573
Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics. CA a Cancer J Clin. 2019;69(5):363-385. https://doi.org/10.3322/caac.21565
Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229-239. https://doi.org/10.1002/mpo.1316
Kobak KA, Greist JH, Jefferson JW, et al. Computerized assessment of depression and anxiety over the telephone using interactive voice response. MD Comput. 1999;16:64-68.
Greist JH, Mundt JC, Kobak K. Factors contributing to failed trials of new agents: can technology prevent some problems? J Clin Psychiatry. 2002;63(Suppl 2):8-13.
Tamburrino MB, Lynch DJ, Nagel RW, Smith MK. Primary care evaluation of mental disorders (PRIME-MD) screening for minor depressive disorder in primary care. Prim Care Companion CNS Disord. 2009;11(6):22782. https://doi.org/10.4088/pcc.08.m00711
First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York Psychiatric Institute; 2002.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. In: Text Revision (DSM-IV-TR). 4th ed. American Psychiatric Association; 2000.
First MB, Gibbon M. The structured clinical interview for DSM-IV axis I disorders (SCID-I) and the structured clinical interview for DSM-IV axis II disorders (SCID-II). In: Hersen M, ed. Comprehensive Handbook of Psychological Assessment; 2003. 4 Volume Set.
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315-1316. https://doi.org/10.1097/jto.0b013e3181ec173d
Morrison AS. Screening for Chronic Disease. 2nd ed. The University of Nebraska Press; 1992.
Sox JHC. Diagnostic decision: probability theory in the use of diagnostic tests: an introduction to critical study of the literature. Ann Intern Med. 1986;104(1):60-66. https://doi.org/10.7326/0003-4819-104-1-60
Murphy JM, Berwick DM, Weinstein MC, et al. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry. 1987;44(6):550-555. https://doi.org/10.1001/archpsyc.1987.01800180068011
Yardeni M, Abebe Campino G, Bursztyn S, et al. A three-tier process for screening depression and anxiety among children and adolescents with cancer. Psycho Oncol. 2020;29(12):2019-2027. https://doi.org/10.1002/pon.5494
Recklitis CJ, Blackmon JE, Chang G. Screening young adult cancer survivors for distress with the Distress Thermometer: comparisons with a structured clinical diagnostic interview. Cancer. 2016;122(2):296-303. https://doi.org/10.1002/cncr.29736
Prasad PK, Hardy KK, Zhang N, et al. Psychosocial and neurocognitive outcomes in adult survivors of adolescent and early young adult cancer: a report from the childhood cancer survivor study. J Clin Oncol JCO. 2015;57(23):7528-2552. https://doi.org/10.1200/jco.2014.57.7528
De R, Zabih V, Kurdyak P, et al. Psychiatric disorders in adolescent and young adult-onset cancer survivors: a systematic review and meta-analysis. J Adolesc Young Adult Oncol. 2020;9(1):12-22. https://doi.org/10.1089/jayao.2019.0097
Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24-31. https://doi.org/10.1016/j.genhosppsych.2015.11.005
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Author; 2013.
Spitzer RL, Kroenke K, Williams JB, et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737-1744. https://doi.org/10.1001/jama.282.18.1737
Vucic V, Radovanovic S, Radevic S, et al. Mental health assessment of cancer patients: prevalence and predictive factors of depression and anxiety. Iran J Public Health. 2021;50:2017. https://doi.org/10.18502/ijph.v50i10.7502
Barriere J, Mari V, Cherikh F, et al. Adaptation and validation of a brief screening questionnaire of depressive disorders in patients with cancer: Q2i study. Bull Cancer. 2015;103(2):138-147. https://doi.org/10.1016/j.bulcan.2015.09.008
Mendonsa RD, Appaya P. Psychiatric morbidity in outpatients of gynecological oncology clinic in a tertiary care hospital. Indian J Psychiatr. 2010;52(4):327. https://doi.org/10.4103/0019-5545.74307
O'Malley PG, Wong PW, Kroenke K, Roy MJ, Wong RK. The value of screening for psychiatric disorders prior to upper endoscopy. J Psychosom Res. 1998;44(2):279-287. https://doi.org/10.1016/s0022-3999(97)00250-x
Warmenhoven F, van Rijswijk E, Engels Y, et al. The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer. 2012;20(2):319-324. https://doi.org/10.1007/s00520-010-1082-8